Anlon Healthcare Limited
Neomile sold 4,07,255 shares of Anlon Healthcare Limited for ₹4.75 Cr at ₹116.64 apiece, decreasing its stake from 5.16% to 4.40% via an open market transaction.
A chemical manufacturing company specializing in the production of pharma intermediates and active pharmaceutical ingredients for the pharmaceutical industry. Incorporated in 2013, Anlon Healthcare focuses on complex chemical synthesis and custom manufacturing solutions serving both domestic and international clients. The company operates vertically integrated manufacturing facilities designed to maintain consistent quality standards and operational efficiency across its diverse product portfolio.
Neomile Growth Fund is a Mumbai-based Category III alternative investment fund managed by NeoMile Capital, investing in a concentrated portfolio of small and mid-cap listed Indian companies.